Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.

Breast cancer research and treatment - 1 Jun 2017

Krammer Julia, Pinker-Domenig Katja, Robson Mark E, Gönen Mithat, Bernard-Davila Blanca, Morris Elizabeth A, Mangino Debra A, Jochelson Maxine S

Abstract excerpt

PURPOSE: To describe imaging findings, detection rates, and tumor characteristics of breast cancers in a large series of patients with BRCA1 and BRCA2 mutations to potentially streamline screening strategies. METHODS: An IRB-approved, HIPAA-compliant retrospective analysis of 496 BRCA mutation carriers diagnosed with breast carcinoma from 1999 to 2013 was performed. Institutional database and electronic medical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Carcinoma, Intraductal, Noninfiltrating

Share to Genetic Carrier Screening

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Neoplasm Staging

Source

Open in PubMed Open full text

Identifiers

PMID: 28343309
DOI: 10.1007/s10549-017-4198-4
PMCID: PMC5490380

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.PMID 28343309Read ↗

Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.Semantic proximity Read ↗

Clinicopathological and imaging features of ductal carcinoma in situ in BRCA1/2 mutation carriers.Semantic proximity Read ↗

The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancerSemantic proximity Read ↗

Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma.Semantic proximity Read ↗

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers.Semantic proximity Read ↗

Imaging Characteristics of Breast Cancers Detected During MRI-Based Surveillance in Hereditary Breast and Ovarian Cancer SyndromeSemantic proximity Read ↗

Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study.Semantic proximity Read ↗

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.Semantic proximity Read ↗

BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.Semantic proximity Read ↗

Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.Semantic proximity Read ↗

Screening in Women With BRCA Mutations Revisited.Semantic proximity Read ↗

BRCAMutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging ConsiderationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.